Article Details

Trillium Therapeutics Inc. (NASDAQ:TRIL) Receives Average Rating of "Hold" from Analysts

Retrieved on: 2020-12-12 12:33:43

Tags for this article:

Click the tags to see associated articles and topics

Trillium Therapeutics Inc. (NASDAQ:TRIL) Receives Average Rating of "Hold" from Analysts. View article details on hiswai:

Excerpt

The <b>biotechnology</b> company reported ($0.58) EPS for the quarter, missing the consensus estimate of ($0.25) by ($0.33). Equities research analysts ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up